The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Iron(II) Binding to Amyloid-β, the Alzheimer’s Peptide
Abstract
Iron has been implicated in Alzheimer's disease, but until now no direct proof of Fe(II) binding to the amyloid-β peptide (Aβ) has been reported. We used NMR to evidence Fe(II) coordination to full-length Aβ40 and truncated Aβ16 peptides at physiological pH and to show that the Fe(II) binding site is located in the first 16 amino-acid residues. Fe(II) caused selective broadening of some NMR peaks that was dependent on the Fe:Aβ stoichiometry and temperature. Analysis of Fe(II) broadening effect in the (1)H, (13)C, and 2D NMR data established that Asp1, Glu3, the three His, but not Tyr10 nor Met35 are the residues mainly involved in Fe(II) coordination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-β peptide
Faller, P., & Hureau, C. (2009) · Dalton Trans. · doi:10.1039/b813398k · Cited by 530
Self-citationHouse, E., Collingwood, J., Khan, A., Korchazkina, O., Berthon, G., & Exley, C. (2004) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6310 · Cited by 294
High‐resolution NMR studies of the zinc‐binding site of the Alzheimer's amyloid β‐peptide
Danielsson, J., Pierattelli, R., Banci, L., & Gräslund, A. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05563.x · Cited by 253
Mandel, S., Amit, T., Bar-Am, O., & Youdim, M. B. H. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.06.001 · Cited by 164
Amyloid-β Binds Cu 2+ in a Mononuclear Metal Ion Binding Site
Karr, J. W., Kaupp, L. J., & Szalai, V. A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0488028 · Cited by 160
Exley, C. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-102-305 · Cited by 107
Research works printed but not linked: 35
- Kozlowski H., 2009, Coord. Chem. Rev., 253, 2665, 10.1016/j.ccr.2009.05.011 · DOI · Paper page
- Smith M. A., 1997, Proc. Natl. Acad. Sci. U.S.A., 94, 9866, 10.1073/pnas.94.18.9866 · DOI · Paper page
- Quintana C., 2006, Struct. Biol., 153, 42, 10.1016/j.jsb.2005.11.001 · DOI · Paper page
- Grundke-Iqbal I., 1990, Acta Neuropathol., 81, 105, 10.1007/BF00334497 · DOI · Paper page
- Meadowcroft M. D., 2009, J. Magn. Reson. Imaging, 29, 997, 10.1002/jmri.21731 · DOI · Paper page
- Casadesus G., 2004, J. Alzheimers Dis., 6, 165, 10.3233/JAD-2004-6208 · DOI
- Smith M. A., 2010, J. Alzheimers Dis., 19, 363, 10.3233/JAD-2010-1239 · DOI · Paper page
- Bishop G. M., 2003, J. Neurosci. Res., 73, 316, 10.1002/jnr.10661 · DOI
- Liu B., 2011, J. Biol. Chem., 286, 4248, 10.1074/jbc.M110.158980 · DOI · Paper page
- Mantyh P. W., 1993, J. Neurochem., 61, 1171, 10.1111/j.1471-4159.1993.tb03639.x · DOI · Paper page
- Rogers J. T., 2008, Biochem. Soc. Trans., 36, 1282, 10.1042/BST0361282 · DOI
- Silvestri L., 2008, J. Cell. Mol. Med., 12, 1548, 10.1111/j.1582-4934.2008.00356.x · DOI
- Duce J. A., 2010, Cell, 142, 857, 10.1016/j.cell.2010.08.014 · DOI · Paper page
- Minicozzi V., 2008, J. Biol. Chem., 283, 10784, 10.1074/jbc.M707109200 · DOI · Paper page
- Syme C. D., 2004, J. Biol. Chem., 279, 18169, 10.1074/jbc.M313572200 · DOI · Paper page
- Dorlet P., 2009, Angew. Chem., Int. Ed., 48, 9273, 10.1002/anie.200904567 · DOI · Paper page
- Drew S. C., 2009, J. Am. Chem. Soc., 131, 1195, 10.1021/ja808073b · DOI · Paper page
- Hureau C., 2009, J. Biol. Inorg. Chem., 995, 10.1007/s00775-009-0570-0 · DOI
- Shearer J., 2008, J. Am. Chem. Soc., 130, 17826, 10.1021/ja805940m · DOI · Paper page
- Hou L., 2006, J. Am. Chem. Soc., 128, 9260, 10.1021/ja046032u · DOI · Paper page
- Hureau C., 2009, Angew. Chem., Int. Ed., 48, 9522, 10.1002/anie.200904512 · DOI
- Eury H., 2011, Angew. Chem., Int. Ed., 50, 901, 10.1002/anie.201005838 · DOI
- Baruch-Suchodolsky R., 2008, Biochemistry, 47, 7796, 10.1021/bi800114g · DOI
- Khan A., 2006, Free Radical Biol. Med., 40, 557, 10.1016/j.freeradbiomed.2005.09.013 · DOI
- Jiang D., 2009, Biochemistry, 48, 7939, 10.1021/bi900907a · DOI
- Cui Q., 2006, Proteins, 62, 578, 10.1002/prot.20781 · DOI
- He Y. N., 2004, Biochemistry, 43, 16254, 10.1021/bi0488193 · DOI
- Rai P., 2005, Nucleic Acids Res., 33, 497, 10.1093/nar/gki192 · DOI
- Bhattacharya S., 1997, Biophys. J., 73, 3241, 10.1016/S0006-3495(97)78349-8 · doi:10.1016/s0006-3495(97)78349-8
- Gaggelli E., 2006, Chem. Rev., 106, 1995, 10.1021/cr040410w · DOI · Paper page
- Gaggelli E., 2003, Magn. Reson. Chem., 41, 877, 10.1002/mrc.1250 · DOI
- Mekmouche Y., 2005, ChemBioChem, 6, 1663, 10.1002/cbic.200500057 · DOI
- Drew S. C., 2009, J. Am. Chem. Soc., 131, 8760, 10.1021/ja903669a · DOI · Paper page
- Opazo C., 2002, J. Biol. Chem., 277, 40302, 10.1074/jbc.M206428200 · DOI · Paper page
- Delgado R., 1991, Anal. Chim. Acta, 245, 271, 10.1016/S0003-2670(00)80232-9 · DOI
Cited by
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185
Self-citationAmyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future
Zhang, Y., Chen, H., Li, R., Sterling, K., & Song, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01484-7 · Cited by 988
Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases)
Kozlowski, H., Luczkowski, M., Remelli, M., & Valensin, D. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.013 · Cited by 437
Untangling Amyloid-β, Tau, and Metals in Alzheimer’s Disease
Savelieff, M. G., Lee, S., Liu, Y., & Lim, M. H. (2013) · ACS Chemical Biology · doi:10.1021/cb400080f · Cited by 400
Metal Ions in Alzheimer’s Disease: A Key Role or Not?
Liu, Y., Nguyen, M., Robert, A., & Meunier, B. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00248 · Cited by 353
Metal-associated amyloid-β species in Alzheimer's disease
Pithadia, A. S., & Lim, M. H. (2012) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.01.016 · Cited by 259
Robert, A., Liu, Y., Nguyen, M., & Meunier, B. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00119 · Cited by 212
Neurodegenerative diseases and exposure to the environmental metals Mn, Pb, and Hg
Charlet, L., Chapron, Y., Faller, P., Kirsch, R., Stone, A. T., & Baveye, P. C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.05.012 · Cited by 92
Self-citationHan, S.-H., Park, J.-C., & Mook-Jung, I. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.004 · Cited by 67
Iron Pathophysiology in Alzheimer’s Diseases
Wang, T., Xu, S.-F., Fan, Y.-G., Li, L.-B., & Guo, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_5 · Cited by 64
Iridoids and other monoterpenes in the Alzheimer’s brain: Recent development and future prospects
Habtemariam, S. (2018) · Molecules · doi:10.3390/molecules23010117 · Cited by 55
Uranga, R. M., & Salvador, G. A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2850341 · Cited by 48
Metadata
- Authors
- Bousejra-ElGarah, F., Bijani, C., Coppel, Y., Faller, P., & Hureau, C.
- Venue
- Inorganic Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2011-07-29
- Volume
- 50
- Issue
- 18
- Pages
- 9024-9030
- ISSN
- 0020-1669 (ISSN-L)
- 1520-510X
- OpenAlex
- W2327309337
- Cited by
- 198
- References
- 7
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.